The Jayne Koskinas Ted Giovanis Foundation for Health and Policy (JKTG Foundation) funds cancer research, policy projects and events that foster collaboration and public discussion to improve the quality, effectiveness and experience of the care patients receive.
DRIVING RESEARCH
"We take a different approach to research and work with people who ask questions science and medicine haven’t yet answered. Many research projects only get support when the answer is largely known, and that is a disservice to us all, especially those diagnosed with and fighting breast cancer. We’re not afraid to try new things and ask questions we don't know the answers to."
Ted Giovanis
GIOVANIS INSTITUTE AT JOHN HOPKINS
Ted Giovanis created the Giovanis Institute for Translational Cell Biology at Johns Hopkins with a $35M, 15-year gift to help researchers learn how cancer spreads and how to stop it more.
Cancer is the second leading cause of death in the U.S., and some estimate that roughly two-thirds of cancer deaths are linked to its spread, or metastasis. The GI Institute focuses on promoting innovation by identifying cellular strategies, developing countermeasures to prevent metastasis and collaborating across disciplines like biology, engineering, and machine learning. "Collaboration empowers new thinking to transform cancer diagnosis and treatment," said Giovanis.
JKTG FOUNDATION RESEARCHERS
Researchers supported by the Jayne Koskinas Ted Giovanis Foundation for Health and Policy challenge the status quo, bringing a multidisciplinary approach to cancer research. We are not interested in cultivating “tried and true.” We are interested in bold ideas, and these are some of the researchers whose work we’ve supported.
Andrew Ewald, Ph.D.
Director, Giovanis Institute for Translational Cell Biology
Johns Hopkins School of Medicine
Mikala Egeblad, Ph.D.
Johns Hopkins School of Medicine
Heiko Enderling, Ph.D.
MD Anderson Cancer Center
Daniele Gilkes, Ph.D.
Johns Hopkins University School of Medicine
Laura H. Heiser, Ph.D.
Oregon Health & Science University
Robert Ivkov, Ph.D.
Johns Hopkins School of Medicine
Charles Perou, Ph.D.
University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill
Shelly Peyton, Ph.D.
University of Massachusetts
Paul Macklin, Ph.D.
Indiana University
Aritro Nath, Ph.D.
City of Hope
*E-cadherin is required for metastasis in multiple models of breast cancer
Published in the journal Nature
*conducted by JKTG-supported researchers
Measuring the quality of health care in the US: Why we are failing and what we can do about it
Published by JKTG Foundation
Problematic risk adjustment in national healthcare safety network measures
Published in the American Journal of Medical Quality
Prediction of bone metastasis in inflammatory breast cancer using a Markov chain model
Published in The Oncologist
Learning-accelerated discovery of immune-tumour interactions
Published in the journal Molecular Systems Design & Engineering
A review of cell-based computational modeling in cancer biology
Published in JCO Clinical Cancer Informatics
Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis
Published in Nature Communications